Skip to main content

Wearable Robotics

HardwarePisa, ItalyFounded 2014· One of 1757 Hardware companies tracked by AMPulse

Develops advanced wearable robotic systems and exoskeletons for neuromotor rehabilitation and industrial assistance.

CEO / Founder
Lucia Lencioni
Team Size
11-50
Stage
Active
Total Funding
$5.4M
Latest Round
Series A
Key Investors
CDP Venture Capital, MITO Technology, LIFTT, SIMEST, RoboIT, Toscana Next

Technology & Products

Key Products

["ALEx RS - Bilateral upper-limb exoskeleton with 5 degrees of freedom (4 active, 1 passive) for post-stroke rehabilitation, CE certified Class IIa medical device","ALEx S (Track-hold) - Rehabilitation device for upper limb passive training with gravity support and motion tracking","Wearable Walker - Lower limb robotic prototype for walking assistance","Industrial Exoskeleton Series - Solutions for manual material handling and overhead work support"]

Technological Advantage

Utilizes a proprietary tendon-actuated transmission system that ensures low weight and high 'transparency' (minimal resistance to natural movement), backed by over 25 years of academic research in human-robot interaction.

Differentiation

Value Proposition

Improves clinical outcomes for neurological patients through high-fidelity robotic assistance and reduces musculoskeletal strain for industrial workers using lightweight, ergonomic exoskeleton technology.

How They Differentiate

Proprietary tendon-actuated transmission system providing high 'transparency' (minimal resistance to natural movement) and low weight compared to traditional rigid-link systems. Integration with Virtual Reality (VR) 'serious games' enhances patient engagement and neuroplasticity.

Market & Competition

Target Customers

Rehabilitation clinics, hospitals, stroke survivors, and industrial manufacturing/logistics companies.

Industry Verticals

["Healthcare / MedTech","Physical Rehabilitation","Industrial Manufacturing","Logistics & Warehousing"]

Competitors

Hocoma (ArmeoPower), Tyromotion (Diego), Ekso Bionics (EksoUE), Myomo (MyoPro)

Growth & Milestones

Growth Metrics

Deployed 50+ robotic units in clinical hospitals and rehabilitation centers across 20 countries; holds 8 proprietary industrial patents.

Major Milestones

["Founded in 2014 as a spin-off from the PERCRO Lab of Scuola Superiore Sant'Anna","Obtained CE Mark and ISO 13485 certification for ALEX RS and ALEX S in 2019","Definitively acquired a family of 8 industrial patents from Scuola Superiore Sant'Anna in 2022","Closed €5M Series A funding round in April 2024 to scale international operations"]

Notable Customers

Clinical hospitals and rehabilitation centers across 20 countries, with over 50 ALEX RS units deployed internationally

https://wearable-robotics.com

Why this company matters

Wearable Robotics occupies a niche at the intersection of clinical neurorehabilitation and industrial ergonomics, offering upper-limb exoskeletons that combine high-fidelity force feedback with virtual reality serious games. Its core differentiator is a proprietary tendon-actuated transmission system that minimizes resistance to natural movement, a design rooted in over 25 years of research at the PERCRO Lab.

The flagship product, ALEx RS, is a bilateral upper-limb exoskeleton with five degrees of freedom (four active, one passive) certified as a Class IIa medical device under CE and ISO 13485. It targets post-stroke rehabilitation in hospitals and clinics, with over 50 units deployed across 20 countries. The company also offers the ALEx S for passive training with gravity support and an industrial exoskeleton series for manual material handling and overhead work.

Wearable Robotics holds a family of eight industrial patents covering kinematics, sensor systems, and actuation, acquired from Scuola Superiore Sant'Anna in 2022. Its partnerships include EPFL, the University Hospital of Geneva, and the University Hospital of Pisa. A €5M Series A round closed in April 2024, backed by CDP Venture Capital and LIFTT, to scale international operations.

The company competes with Hocoma's ArmeoPower, Tyromotion's Diego, Ekso Bionics' EksoUE, and Myomo's MyoPro. Its tendon-driven architecture offers a lighter, more transparent alternative to rigid-link systems, though the small installed base and reliance on clinical reimbursement pathways remain scaling constraints.